Authors


John Hey, PhD

Latest:

Understanding Patient Characteristics of Phase 3 APOLLOE4 Trial of ALZ-801 in Alzheimer Disease: John Hey, PhD

The chief scientific officer at Alzheon provided insight on the preliminary imaging findings of patients enrolled in the phase 3 APOLLOE4 study assessing ALZ-801 as a potential treatment for Alzheimer disease. [WATCH TIME: 3 minutes]


Blanca Marquez de Prado, PhD

Latest:

Clinical Implications on the Influence of the Microbiome on Migraine Regulation: Blanca Marquez de Prado, PhD

The research project manager of the headache program at the Children's Hospital of Philadelphia discussed data that suggest that an unhealthy and imbalanced microbiome may exacerbate the frequency, severity, and duration of migraines. [WATCH TIME: 4 minutes]


Johanna L. Watkinson, APN

Latest:

The Role of Nurse Practitioners in Multidisciplinary Stroke Care: Johanna L. Watkinson, APN

The acute care nurse practitioner at Overlook Medical Center spoke to the importance of having a multidisciplinary team when treating patients with stroke and the gaps that advanced practice providers can help fill.


Sarah Yang, MD

Latest:

An Overview of Therapeutic Options for Amyotrophic Lateral Sclerosis

With an anticipated life expectancy of 3 years from the time of symptom onset, an effective treatment strategy is essential in ALS—and recent therapeutic progress has built a foundation of hope for the community.


Yolanda A. Yu, DO

Latest:

Pediatric Sleep Disorders: Assessment and Treatment

The long-term consequences of untreated—and prevalent—sleep disorders in children and adolescents point to a need for a focus on this field of care.


Rachelle Ramirez

Latest:

In Memoriam: A Loving Tribute to June Halper

NeurologyLive joins the CMSC in mourning the loss of founder and CEO,June Halper, MSN, APC-C, MSCN, FAAN.


Carolyn H. Goldschmidt, DO

Latest:

Retrospectively Exploring De-Escalation of Multiple Sclerosis Medication: Carolyn H. Goldschmidt, DO

The neurologist at NorthShore University Health System in Chicago discussed a retrospective study on patients with multiple sclerosis who switched from high or moderate efficacy disease-modifying therapies to lower efficacy ones. [WATCH TIME: 5 minutes]


Gil Rabinovici, MD

Latest:

Exploring Blood-Based Biomarkers and Treatment Eligibility in Alzheimer Disease: Gil Rabinovici, MD

The professor of neurology and radiology at University of California, San Francisco, discussed the potential of blood-based biomarkers in Alzheimer treatment eligibility, highlighting current limitations and the importance of safety monitoring. [WATCH TIME: 7 minutes]


Vanessa Hinson, MD, PhD

Latest:

Episode 5: Emerging Women-Related Research and Closing Thoughts

The group of women neurologists provided commentary on the critical areas of women-focused research in neurology, from clinical trial participation to addressing workforce challenges.


Aishwarya Taneja, MD, FAAP

Latest:

College Checklist for People Living With Migraine

Transition to college life poses unique challenges for students living with migraine, and a comprehensive checklist helps ensure they are prepared for this critical phase.


Anne Marie Morse, DO, FAASM

Latest:

NeuroVoices: Anne Marie Morse, DO, FAASM, on the Impact of the Once-Nightly Sodium Oxybate Approval for Pediatric Narcolepsy

The director of Child Neurology and Pediatric Sleep Medicine at Geisinger Janet Weis Children's Hospital talked about how the recent approval of once-nightly sodium oxybate for pediatric narcolepsy enables more effective and manageable treatment options for children and families.



Eytan Raz, MD, PhD

Latest:

Treatment Options and Outcomes of Cervical Artery Dissection in Adults: Eytan Raz, MD, PhD

The neurointerventional radiologist at NYU Langone provided clarity on the individualized treatment options for cervical artery dissection following a scientific statement paper from the American Heart Association. [WATCH TIME: 7 minutes]


Connor Iapoce

Latest:

FDA Approves Tirzepatide as First Treatment for Obstructive Sleep Apnea and Obesity

Adults with obstructive sleep apnea who receivied tirzepatide achieved an average of up to 20% weight loss and experienced at least 25 fewer breathing interruptions for each hour slept.


Kathrin Doppler, MD

Latest:

Key Sessions and Real-World Case Learning at PNS 2025: Kathrin Doppler, MD; Vincent Timmerman, PhD, MSc

A pair of committee chairs for the Peripheral Nerve Society’s Annual Meeting shared key sessions and trends clinicians should follow at the upcoming meeting, emphasizing collaboration, trial data, and clinical relevance. [WATCH TIME: 3 minutes]


Emad Estemalik, MD

Latest:

Expanding the Migraine Treatment Protocol Beyond CGRPs: Emad Estemalik, MD

The director of the headache section at Cleveland Clinic detailed some of the emerging nonpharmacological preventive methods for migraine, as well as where research is headed following the explosion of CGRP-targeting therapies. [WATCH TIME: 6 minutes]


Adam Mecca, MD, PhD

Latest:

Mechanistic Potential of Synapse-Targeted Agent ALX-001 for Alzheimer Disease: Adam Mecca, MD, PhD

The associate director of the Alzheimer’s Disease Research Unit at the Yale School of Medicine discussed the mechanism of action of ALX-001, a highly selective agent in development for neurodegenerative diseases. [WATCH TIME: 5 minutes]


Ashley Curtis, PhD

Latest:

Role of Sleep Chronotype, Circadian Rhythm in Neurocognitive Health: Ashley Curtis, PhD

The assistant professor at the University of South Florida provided perspective on the influence of circadian rhythm in neurocognitive health and the possibilities of screening for circadian rhythm issues for large-scale clinical trials. [WATCH TIME: 4 minutes]


Boris Kantor, PhD

Latest:

Early Intervention and Disease Prevention With a Novel Epigenome Approach: Boris Kantor, PhD

The associate research professor of neurobiology at Duke University discussed an innovative epigenome editing approach that shows promising prospects for patient improvement, disease prevention, and potential use in Alzheimer disease prophylactic work. [WATCH TIME: 3 minutes]


Melanie Leitner, PhD

Latest:

Pridopidine’s Impact on ALS, Assessing Results From HEALEY ALS Platform Trial: Melanie Leitner, PhD

The consultant and founder of Accelerating NeuroVentures talked about the pridopidine arm from the HEALEY ALS Platform trial, which showed significant benefits in speech measures. [WATCH TIME: 5 minutes]



Allison Brashear, MD, MBA

Latest:

AUPN Leadership Minute Episode 29: Transitioning From Chair to VP and Dean

Episode 29 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Allison Brashear MD, MBA, of University at Buffalo. [WATCH TIME: 5 minutes]


Diana Gallagher, MD

Latest:

Additive Potential of BTK Inhibitors in Multiple Sclerosis Treatment Paradigm: Diana Gallagher, MD

The head of Biogen’s MS and Immunology Department Unit detailed the potential of combination approaches to treat MS, including the reasons for diroximel fumarate in the newly initiated phase 2 FUSION study. [WATCH TIME: 3 minutes]


Lauren Sansing, MD, MS, FAHA

Latest:

Highlights of ISC 2024, Trials and Future Innovations for Stroke Care: Tudor Jovin, MD; Lauren Sansing, MD, MS, FAHA

The medical director of the Cooper Neurological Institute and the professor of neurology at Yale University School of Medicine shared a few highlights from research presented at ISC 2024. [WATCH TIME: 7 minutes]


Victoria Johnson

Latest:

Cure Rare Disease Identifies Toxicity Responsible for DMD Gene Therapy Death

Caution is warranted for older patients with Duchenne muscular dystrophy who are receiving gene therapy, according to details of a patient death in a single patient trial.


Melody Schaeffer, PhD, MPH

Latest:

Improving Timely ALS Diagnosis With the thinkALS Toolkit: Melody Schaeffer, PhD, MPH

The senior director of mission programs at The ALS Association discussed how the thinkALS Toolkit can aid general neurologists in identifying and referring suspected cases more efficiently. [WATCH TIME: 5 minutes]


Anna Kratz, PhD

Latest:

Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD

Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]


Amit Mehta, MD

Latest:

Read All About It: How On-Demand Therapy Has Changed the PD Landscape

As therapeutic development has advanced in Parkinson disease management, the introduction of on-demand options have extended ON time for patients and altered the paradigm of care.


Justin Davanzo, MD

Latest:

Chronic Pain Treatment Options for an Aging Population in Neurology: Justin Davanzo, MD

The neurosurgeon in the department of neurology at Allegheny Health Network talked about the increasing prevalence of chronic pain as the population ages and the treatment options available to patients to provide relief. [WATCH TIME: 5 minutes]


Claudia Asencio, MA

Latest:

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.

© 2025 MJH Life Sciences

All rights reserved.